11,829 Shares in Merck KGaA $MKGAF Acquired by Wallace Capital Management Inc.

Wallace Capital Management Inc. purchased a new position in Merck KGaA (OTCMKTS:MKGAF) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund purchased 11,829 shares of the company’s stock, valued at approximately $1,520,000. Merck KGaA accounts for about 0.2% of Wallace Capital Management Inc.’s investment portfolio, making the stock its 29th largest position.

Several other hedge funds and other institutional investors have also recently bought and sold shares of MKGAF. Legal & General Group Plc purchased a new stake in shares of Merck KGaA during the second quarter valued at approximately $2,425,225,000. Barrow Hanley Mewhinney & Strauss LLC purchased a new position in shares of Merck KGaA in the second quarter worth $942,087,000. Caisse de depot et placement du Quebec purchased a new position in shares of Merck KGaA in the second quarter worth $571,582,000. Canada Pension Plan Investment Board bought a new stake in Merck KGaA during the 2nd quarter valued at $536,694,000. Finally, Jupiter Topco LLC bought a new stake in Merck KGaA during the 2nd quarter valued at $501,199,000. Institutional investors own 0.10% of the company’s stock.

Merck KGaA Trading Up 0.4%

Shares of MKGAF opened at $164.58 on Thursday. The stock has a market capitalization of $21.27 billion, a P/E ratio of 25.13 and a beta of 0.96. Merck KGaA has a twelve month low of $116.68 and a twelve month high of $175.56. The company has a quick ratio of 0.84, a current ratio of 1.31 and a debt-to-equity ratio of 0.27. The firm has a fifty day simple moving average of $163.19 and a two-hundred day simple moving average of $148.83.

Merck KGaA Profile

Merck KGaA, headquartered in Darmstadt, Germany, is a long-established multinational chemical and pharmaceutical company with roots dating back to 1668. Operating under the brand Merck Group (and using distinct consumer-facing names in certain regions to avoid confusion with other companies of similar name), the company is privately controlled by the Merck family and organizes its activities across multiple business units that serve customers in Europe, the Americas, Asia-Pacific and beyond.

The company’s operations are organized mainly into three businesses.